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1022Ectodysplasin A Pathway Contributes to
Human and Murine Skin Repair
Clare L. Garcin1, Kenneth M. Huttner2, Neil Kirby2, Pascal Schneider3 and Matthew J. Hardman1The highly conserved ectodysplasin A (EDA)/EDA receptor signaling pathway is critical during development
for the formation of skin appendages. Mutations in genes encoding components of the EDA pathway disrupt
normal appendage development, leading to the human disorder hypohidrotic ectodermal dysplasia. Sponta-
neous mutations in the murine Eda (Tabby) phenocopy human X-linked hypohidrotic ectodermal dysplasia.
Little is known about the role of EDA signaling in adult skin homeostasis or repair. Because wound healing
largely mimics the morphogenic events that occur during development, we propose a role for EDA signaling
in adult wound repair. Here we report a pronounced delay in healing in Tabbymice, demonstrating a functional
role for EDA signaling in adult skin. Moreover, pharmacological activation of the EDA pathway in both Tabby
and wild-type mice significantly accelerates healing, influencing multiple processes including re-
epithelialization and granulation tissue matrix deposition. Finally, we show that the healing promoting ef-
fects of EDA receptor activation are conserved in human skin repair. Thus, targeted manipulation of the EDA/
EDA receptor pathway has clear therapeutic potential for the future treatment of human pathological wound
healing.
Journal of Investigative Dermatology (2016) 136, 1022e1030; doi:10.1016/j.jid.2015.09.002INTRODUCTION
Hypohidrotic ectodermal dysplasia (HED) is a well-
characterized human disease affecting the morphology
and number of skin appendages, principally the hair follicles
(HFs), teeth, and exocrine glands (Mikkola, 2009; Mikkola
and Thesleff, 2003; Naito et al., 2002). HED, the most com-
mon of the ectodermal dysplasias, is caused by mutations
to the ectodysplasin signaling pathway, which is essential for
in utero development of ectoderm-derived appendages. The
main axis of the pathway comprises the ligand ectodysplasin
A (EDA, encoded in mice by Tabby), ectodysplasin A receptor
(EDAR, encoded by downless/Sleek), and the adaptor mole-
cule EDAR-associated protein with a death domain (encoded
by crinkled). Mutations in any of these pathway components
leads to human HED, which is phenocopied in mice (Cui and
Schlessinger, 2006). Mutations in the X-linked EDA gene
underlie most ectoderm dysplasia cases (X-linked HED
[XLHED]) (Huttner, 2014; Monreal et al., 1998).
EDA, a member of the tumor necrosis factor family of
signaling molecules, exists in two highly homologous iso-
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an o2001; Mikkola and Thesleff, 2003). EDA1 is specific for
the type I transmembrane protein EDAR, whereas EDA2 is
specific for the type III, X-linked transmembrane receptor
(Mikkola and Thesleff, 2003; Yan et al., 2000). Mutations to
EDA2 do not result in XLHED; however, this ligand is thought
to play a role in hair loss during adulthood (Brosh et al.,
2010). To invoke EDAR signaling, EDA ligands are shed
from the cell surface before receptor binding. Receptor
activation initiates association with the C-terminal death
domain of EDAR-associated protein with a death domain,
which creates a complex capable of interacting with tumor
necrosis factor receptor-associated factors (Headon et al.,
2001; Yan et al., 2000). Activated tumor necrosis factor
receptor-associated factor molecules interact with IkB kinase
releasing NF-kB family members from their cystolic in-
hibitors to enter the nucleus and initiate transcription of
target genes.
In line with the phenotype of XLHED patients, EDAR
pathway activation has primarily been linked to the window
when appendages develop in utero. In mice, Edar mRNA
is expressed from E14 in the developing epidermal basal
layer, localized to preappendage placodes (Headon and
Overbeek, 1999). The resultant EDAR protein remains
localized to the placode into the final postnatal stages of HF
development. In contrast, few studies have explored po-
tential roles for EDAR signaling in adult tissue. Kowalczyk-
Quintas et al. (2015) recently showed that Edar is expressed
within the sebaceous glands of adult mice, and Inamatsu
et al. (2006) reported Edar expression in the epidermal
cells surrounding the dermal papilla. Moreover, Fessing
et al. (2006) described EDAR expression in the secondary
hair germ of telogen HFs, proposing that EDAR signaling
is important for adult hair cycle (HC) regulation, particu-
larly control of catagen onset through the up-regulation of
X-linked inhibitor of apoptosis.s. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. This is
pen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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EDA Involvement in Wound HealingHair cycling and wound healing are both examples of when
major morphogenic changes occur in adult skin, a tissue that
is normally under strict homeostatic control. To achieve this,
numerous “developmental” signaling pathways are “reused”
in the adult tissue (Stenn and Paus, 2001). Recently, we
demonstrated a novel link between HC and the speed of adult
skin healing, with a near doubling of healing efficiency in skin
containing anagen HC stage follicles (Ansell et al., 2011). This
led us to hypothesize an as yet unidentified role for the EDAR
signaling pathway in adult skin wound healing. This hypoth-
esis is supported by a case study from Barnett et al. (1979)
describing poor skin graft healing in an XLHED patient.
Here we provide functional demonstration that EDAR
signaling plays an important role in adult skin wound heal-
ing. Specifically, mice lacking the ligand EDA (Tabby) dis-
played reduced healing ability, whereas EDAR signaling
augmentation promoted healing, not only in Tabby but also
in wild-type (WT) mice. EDAR signaling manipulation altered
multiple aspects of healing, including peri-wound prolifera-
tion, epidermal migration, and collagen deposition. Finally,
we show that EDAR stimulation is able to promote human
skin healing and is thus an attractive target for future thera-
peutic manipulation.Figure 1. Edar expression increases at the wound edge. (a) In normal (unwoun
epidermis and within the hair follicles. (b) In a 24-hour wound, immunoreactivi
interfollicular epidermis. (c) In a 72-hour wound, immunoreactivity is apparent
keratinocytes within the neo-epidermis, which appear to be actively migrating b
membrane separating interfollicular epidermis and dermis. Yellow dotted line in
Enlargement of images shown in aec. Bar ¼ 50 mm (aec) and 20 mm (deg). EDRESULTS
Eda null (Tabby) mice exhibit delayed wound healing, which
can be restored by acute pathway activation. First, we pro-
posed that a role for Edar signaling during wound healing
would likely be reflected in wound edge induction. Thus, we
analyzed Edar expression by immunofluorescence in both
unwounded and wounded skin (Figure 1). We noted immu-
noreactivity with an anti-Edar antibody in the epidermis of
unwounded skin (Figure 1a and e), which appeared
expanded in the peri-wound interfollicular epidermis (IFE) of
24- (Figure 1b and f) and 72- (Figure 1ceg) hour wounds. To
test the hypothesis that EDAR signaling was necessary for
timely healing, we first examined the rate of wound repair in
Eda null (Tabby) mice. We report significantly delayed
excisional wound healing in the absence of EDA (Figure 2).
Tabby wounds were larger than those in WT both macro-
scopically (Figure 2a) and microscopically (Figure 2b and c),
quantified by an increased wound width and delayed rate of
re-epithelialization (Figure 2e and f). To confirm that this
healing delay was due to EDAR signaling deficiency and not
phenotypic differences in Tabby skin, we also performed in
utero correction of the Tabby phenotype using the validated
EDAR-activating antibody mAbEDAR1 (Gaide and Schneider,ded skin), Edar immunoreactivity can be observed in the basal layer of the
ty appears to be present in basal and suprabasal layers of the peri-wound
in peri-wound interfollicular epidermis. Staining intensity appears elevated in
eneath the scab (white arrow and d). White dotted line denotes basement
dicates wound tissue or scab. Green arrow denotes wound edge. (eeg)
AR, ectodysplasin A receptor.
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Figure 2. Absence of EDAR signaling delays murine wound healing, which can be rescued by acute restoration of EDAR signaling. (aed) Representative
macroscopic (a) and microscopic (bed) hematoxylin and eosinestained images of 6-mm excisional wounds at day 3 after wounding from wild-type (WT),
Tabby, and mAbEDAR1-treated Tabby mice. All experimental groups were in an equivalent telogen stage of the hair cycle. Black arrows denote wound
margin. Red arrows denote the neo-epidermal front. (e, f) Quantification of histological wound parameters reveals significantly delayed healing in Tabby
mice, which can be rescued to WT levels by administration of mAbEDAR1. (gei) Hyperproliferation at the wound edge, (marked by keratin 6
immunohistochemistry) is extended in Tabby mice (h) compared to WT (g), but can be restored by administration of mAbEDAR1 (i) and quantified (j).
(k, l) Proliferation is significantly less in Tabby peri-wound interfollicular epidermis (k) and HF (l) than WT, as quantified by BrdU incorporation assay. Values are
given as mean  standard error of the mean. n ¼ 6. EDAR, ectodysplasin A receptor; IFE, interfollicular epidermis; HF, hair follicle. *P < 0.05. Bar ¼ 200 mm.
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10242003; Kowalczyk et al., 2011). Healing in adult mAbEDAR1-
rescued Tabby mice (i.e., phenotypically normal but EDA
deficient) remained delayed and indistinguishable from
nonrescued Tabby mice (data not shown). Thus, develop-
mentally specified structural changes in Tabby skin are un-
likely to contribute to the observed adult wound healing
phenotype.
Finally, we explored the effect of locally activating Edar
signaling in adult Tabby mouse wounds. Here, mAbEDAR1
administered directly to the wound site (by subcutaneous
injection) 24 hours before injury entirely rescued the healing
delay in Tabby mice (Figure 2def). Specifically, the rate of
re-epithelialization is increased, and wound width is signifi-
cantly decreased compared to Tabby, generating a healing
phenotype more in line with WT wounds. In line with
previous delayed healing murine models, including the
HF-deficient tail model (Langton et al., 2008), we observedJournal of Investigative Dermatology (2016), Volume 136extended epidermal activation (keratin 6 expression) in Tabby
wounds (Figure 2j) (Langton et al., 2008). Local administration
of mAbEDAR1 fully rescued this phenotype, restoring normal
peri-wound IFE expression of keratin 6 (Figure 2gej). Induc-
tion of wound edge epithelial proliferation is a key aspect of
HC-modulated healing (Ansell et al., 2011). Peri-wound
epithelial proliferation, measured by BrdU incorporation
assay, was significantly decreased in Tabbymice compared to
WT in both IFE and HF (Figure 2k and l).
Activation of EDAR signaling accelerates healing in WT
mice. To further explore the therapeutic potential of EDAR
signaling activation, we next administered mAbEDAR1
locally to the wound site 24 hours before wounding in
WT mice. WT mAbEDAR1-treated wounds displayed acc-
elerated healing, with a clear induction of re-epithelialization
(Figure 3aed). Peri-wound proliferation levels were assessed
by BrdU incorporation assay. In contrast to Tabby mice,
Figure 3. EDAR signaling activation promotes healing in wild-type mice. (a, b) Representative histology of C57 Bl/6 mouse wounds collected 3 days after
wounding locally treated with mAbEDAR1 or vehicle (phosphate buffered saline) at the time of wounding. Black arrows denote wound edge. Red arrows denote
migration of neo-epidermal tongue. (c, d) Quantification of healing parameters reveals faster healing following mAbEDAR1 treatment. (e, f) BrdU incorporation
assay indicates that mAbEDAR1 treatment does not alter proliferation within the peri-wound interfollicular epidermis (marked by white dashed line). (g, h)
Instead a strong trend toward increased proliferation was observed in peri-wound hair follicles. (i) Quantification of picro Sirius red staining (k) to reveals
significantly higher granulation tissue collagen content in mAbEDAR1-treated mice with a specific increase in fine collagen fibers as shown by green or yellow
staining. (i, j) Representative immunofluorescence for collagen 3 mirrors data shown in k. Values are given as mean  standard error of the mean. n ¼ 5. EDAR,
ectodysplasin A receptor. **P < 0.01. Bar ¼ 150 mm (a, b), 25 mm (e), 30 mm (g), 100 mm (i), 50 mm (j).
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EDA Involvement in Wound HealingmAbEDAR1-treated WT mice displayed increased prolifera-
tion only in peri-wound HFs and not IFE (Figure 3eeh).
During development, EDA/EDAR is essential for epidermal/
dermal cross-talk required for effective appendage morpho-
genesis. Thus, EDAR signaling could have nonepidermal
roles in skin homeostasis and repair. Indeed, careful analysis
revealed increased wound collagen content in mAbEDAR1-
versus placebo-treated WT mice (Figure 3i and k). Specif-
ically, picro Sirius red staining revealed increased collagen
deposition in mAbEDAR1-treated wounds, in addition to a
defined increase in the proportion of fine (green) fibers
(Figure 3i and k). Immunofluorescence for Col3a1 confirms
increased wound bed collagen in mAbEAR1-treated mice,
despite no reports of active EDAR signaling in fibroblasts
(Figure 3j). We note that in a previous transcriptional
study, Cui et al. (2002) reported up-regulation of Col1a1 and
Col3a1 in adult Tabby skin. However, they also reported
increased expression of Col3a1 in EDA overexpressing (EDA-
A1) transgenic mice, suggesting complex paracrine signaling
(Cui et al., 2002).
EDAR signaling activation restores healing in ovariecto-
mized (OVX) mice. OVX mouse provides a widely used,physiologically relevant model of delayed healing (Emmerson
and Hardman, 2012; Hardman et al., 2008) in which to test
the beneficial effects of EDAR signaling activation. Here, OVX
mice received mAbEDAR1 or placebo local to the wound
site 24 hours before wounding. In comparison to control, OVX
mice treated with mAbEDAR1 displayed significantly acceler-
ated healing, with increased re-epithelialization and decreased
wound area compared to control (Figure 4aed). Similarly to
WT mice we observed no differences in peri-wound IFE
proliferation but a strong trend toward increased peri-wound
HF proliferation (Figure 4eeh) in mAbEDAR1-treated OVX
mice. This intriguing HF-specific peri-wound proliferative
response is in linewith the findings of Fessing et al. (2006), who
reported a role for EDAR signaling in adult HF cycling.
Given that both epidermal and dermal aspects of healing
were affected in WT mice, we investigated the collagen
content of OVX wounds by Masson trichrome staining. Here,
collagen content in OVX þmAbEDAR1 is greater than in
placebo-treated mice (Figure 4i and j).
Activation of EDAR signaling promotes human healing. The
EDAR signaling pathway is highly conserved between mouse
and human, as highlighted by the similarities in the XLHEDwww.jidonline.org 1025
Figure 4. EDAR signaling activation promotes healing in ovariectomized (OVX) mice. (a, b) Representative histology of C57 Bl/6 OVX mouse wounds
collected 3 days after wounding locally treated with mAbEDAR1 or vehicle (phosphate buffered saline) at the time of wounding. Black arrows denote wound
edge. Red arrows denote migration of neo-epidermal tongue. (c, d) Quantification of healing parameters reveals faster healing following mAbEDAR1 treatment.
(e, f) Representative Ki67 immunohistochemistry revealing no difference in interfollicular epidermal proliferation but increased HF proliferation in mAbEDAR1-
treated OVX mice, quantified in gej. Masson trichrome staining reveals increased collagen deposition in mAbEDAR1-treated OVX wounds compared to control
treated. Insets show magnified collagen fibers (blue). Values are given as mean  standard error of the mean. n ¼ 5. EDAR, ectodysplasin A receptor. *P < 0.05.
Bar ¼ 200 mm (a, b), 150 mm (e, f), 200 mm (i, j), 50 mm (insets).
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1026and Tabby developmental phenotypes. However, no study
to date has demonstrated a role for EDAR signaling in adult
human tissue. We thus assessed the potential of EDAR acti-
vation to promote human skin wound healing. First, mAbE-
DAR1 treatment in the EDAR-responsive human HaCaT
keratinocyte cell line (Swee et al., 2009) resulted in a statis-
tically significant dose-dependent increase in scratch wound
closure, demonstrating that human keratinocytes are compe-
tent to respond to exogenous pathway activation (Figure 5a
and b). Increased scratch wound closure may indicate that
activation of Edar signaling can increase cell proliferation
in vitro. Although we did not find this to be the case, careful
analysis of cell migration in vitro indicates that Edar signaling
can increase cell motility (see Supplementary Figure S1 on-
line). We also investigated the ability of primary human
keratinocytes to respond to mAbEDAR1 treatment and found
that scratch wound closure in this model was also significantly
accelerated (Figure 5c and d). To confirm efficacy at the
physiological level, we turned to the validated human whole
skin ex vivo wound model (Stojadinovic and Tomic-Canic,
2013). In this ex vivo partial-thickness human skin wound
model, direct topical administration of mAbEDAR1 signifi-
cantly increased both wound re-epithelialization (Figure 5e
and f) and peri-wound proliferation (Figure 5g and h).Journal of Investigative Dermatology (2016), Volume 136DISCUSSION
Timely wound healing requires the communication of mul-
tiple cell types, a phenomenon for which the EDAR pathway
is essential during in utero development, as highlighted by
the XLHED disease phenotype. This study discusses a previ-
ously unreported direct link between EDAR signaling and
wound healing. We found immunoreactivity with an anti-
Edar antibody to be increased in peri-wound IFE compared
to unwounded IFE, and, more importantly, in the absence of
active EDAR signaling wound healing was significantly
delayed. Moreover, local activation of EDAR signaling pro-
moted healing in EDAR-deficient mice, a noneEDAR-linked
mouse model of delayed healing and crucially in ex vivo
human wounds. Surprisingly, EDAR deficiency/treatment ef-
fects are not exclusively confined to the epidermis but also
manifest in the dermis.
Reports of EDAR expression in adult murine skin (Fessing
et al., 2006; Kowalczyk-Quintas et al., 2015) suggested an
active role for EDA/EDAR signaling postnatally. Given
that the role of EDA/EDAR signaling is predominantly in the
rearrangement of the epidermis into placodes during
development (Ahtiainen et al., 2014; Mustonen et al., 2004;
Schmidt-Ullrich et al., 2006), we focused on epithelial as-
pects of the wound phenotype, reporting EDAR-dependent
Figure 5. EDAR signaling promotes human wound healing. (a, b) In vitro treatment with mAbEDAR1 (10 mg or 50 mg in 500 ml of media) promotes human
keratinocyte cell line (HaCaT cells) scratch wound closure (24 hours after scratch) compared to phosphate buffered saline (PBS)etreated cells. (c, d) In vitro
treatment with mAbEDAR1 (50 mg in 500 ml of media) promotes primary human keratinocyte scratch closure compared to Aprily-treated control cells. (e, f) The
3-mm partial-thickness biopsy wounds in ex vivo cultured skin were treated with mAbEDAR1 (100 mg in 10 ml of PBS) or PBS and left to heal ex vivo. (e) Images
display representative keratin 14 staining. Black arrows denote wound edge. Green arrows denote furthest point of neo-epidermal tongue. (f) Quantification of
accelerated healing at 3 days after wounding. (g, h) Proliferation is increased in human ex vivo skin wounds treated with mAbEDAR1 compared to PBS-treated
wounds, quantified from Ki67 immunohistochemistry (g). Values are given as mean  standard error of the mean. n ¼ 4. EDAR, ectodysplasin A receptor. *P <
0.05; **P < 0.01. Bar ¼ 200 mm (a, c, e), 20 mm (g).
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epithelialization. The re-epithelialization phenotype partic-
ularly fits with the report of Mustonen et al. (2004) in which
overactivation of EDAR (K14tg-EDAR mice) during develop-
ment resulted in an increase in placode size, that is, an
EDAR-dependent increase in cell migration. Our in vitro
analysis of cell motility provides further evidence that
Edar signaling may influence cell migration during re-
epithelialization.
Our analysis of proliferation in mAbEDAR1-treated WT
mice revealed no difference in wound edge IFE proliferation
but an clear EDAR dependency of wound edge HF prolifer-
ation. That HF cells would be more capable of responding
to EDAR signaling is in line with the findings of Fessing et al.(2006), who described a postnatal role for EDAR in HC. We
note with interest that during development, pre-appendage
placode proliferation was unaltered in K14-EDAtg mice
(Mustonen et al., 2004). Thus, it seems that the EDAR
pathway has greater influence over appendage proliferation
in adulthood than development, or that additional wound-
derived signals contribute to the observed effects in adult
skin. HF cell involvement in wound healing has been well
characterized in several elegant studies (Ito et al., 2005; Levy
et al., 2007; Mardaryev et al., 2011; Page et al., 2013), and it
is possible that Edar signaling may regulate the involvement
of different HF cell populations. This is particularly inter-
esting in the context of HF stem cell contribution to healing,
which seems o be influenced by the stage of repair.www.jidonline.org 1027
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1028Intriguingly, we also observed increased peri-wound
sebaceous gland proliferative response in mAbEDAR1
treated mice (data not shown). Mechanistically, the prolif-
eration inducing effects of EDAR are most likely explained
by the pathway convergence on Cyclin D1, which will drive
cell cycle progression (Schmidt-Ullrich et al., 2006). More
interesting still, it remains unclear what signals are involved
in communicating an injury response signal to peri-wound
follicles. While several candidates have been suggested
(Chen et al., 2015) it is tempting to speculate that EDAR
may be involved in this initial wound-HF cross-talk. Here,
we note with interest that Inamatsu et al. (2006) have pre-
viously reported Edar-expressing ectopic HFs when fetal
dermis is recombined with adult epidermis, further sup-
porting the concept that adult skin can reactivate embry-
onic processes under specific circumstances (Inamatsu
et al., 2006).
That we observe alterations in dermal aspects of healing
when the EDAR pathway is stimulated was unexpected,
given that there are no reports of EDAR expression in
fibroblasts. Increased wound collagen following mAbE-
DAR1 treatment could be explained by secondary signaling
and epidermal-dermal cross-talk. A more simple explana-
tion would be that this could be a reflection of a more
progressed stage of healing. However, observations of Cui
et al. (2002), who report an increase in collagen mRNA
expression in EDA-overexpressing mice, suggest the former
explanation.
The highly conserved nature of the EDAR pathway (Iida
et al., 2014; Lough et al., 2013; Pantalacci et al., 2008)
led us to test whether the effects of EDAR signaling on
wound healing would also be applicable to human skin
healing. EDAR activation in the EDAR-expressing (Swee
et al., 2009) HaCaT cell line (human keratinocyte)
increased the rate of scratch wound closure. Moreover, in
primary human keratinocytes and the whole human skin
ex vivo wound model, we also observed a marked
improvement in re-epithelialization after EDAR signaling
activation. To our knowledge this is a previously unre-
ported demonstration that EDAR signaling can directly
influence keratinocyte proliferation and migration within
human skin.
In summary, our data reveal a previously unidentified
role for EDA/EDAR signaling in adult cutaneous wound
healing in both mice and humans. Surprisingly we show
the EDA/EDAR pathway to be involved in multiple aspects
of healing, despite EDAR expression being epidermally
restricted. However, the complex role of this pathway
in coordinating HF morphogenesis, in which both
epidermal and dermal skin components contribute, fully
support our observations (Mustonen et al., 2004; Schmidt-
Ullrich et al., 2006). In a prior publication we demon-
strated a strong link between HC stage and wound healing
outcome (Ansell et al., 2011). The concept of manipulating
HC to promote wound healing is experimentally attractive
but likely to prove clinically challenging (Jimenez et al.,
2012, 2015). We suggest that targeting the EDA/EDAR
pathway offers a more practical, therapeutically attractive
solution.Journal of Investigative Dermatology (2016), Volume 136MATERIALS AND METHODS
Wounding
All animal procedures were approved by the UK Home Office
(Project License 40/3202) after local ethical approval. Seven-week-
old male Tabby (FVB/N) or WT mice (FVB/N or C57) were
anaesthetized (isoflurane) and wounded following our established
protocol (either two dorsal full-thickness 1-cm incisions or two
full-thickness 6-mm excisions) (Ansell et al., 2014). Mice were
individually housed postoperatively and left to heal by secondary
intention with analgesia (buprenorphine). Anti-EDAR1 monoclonal
mouse IgG1 (mAbEDAR1) or placebo (Aprily1 isotype-matched
antibody or phosphate buffered saline) was administered 24
hours before wounding (2 mg/kg) via subcutaneous injection at
the wound site. BrdU was administered intraperitoneally 2 hours
before sacrifice. Three days after wounding, samples (wounds and
skin) were excised, bisected, and fixed in 10% buffered formalin
(histology) or snap frozen (biochemical analysis).
Tissue processing, histology, and analysis
Histological sections were prepared from fixed, paraffin-embedded
tissue. Five-micrometer sections were stained with hematoxylin and
eosin (Vector, Peterborough, UK), Sirius red (in picric acid), orMasson
trichrome, or underwent immunohistochemical analysis with the
following antibodies: anti-Edar (R&D, Abingdon, UK, Systems AF745)
anti-keratin 6 (Covance, NJ, PRB-169P), anti-keratin 14 (Covance
PRB-155P-100), anti-BrdU (Abcam, ab6326), or anti-Col3a1 (Santa
Cruz, Heidelberg, Germany, sc28888). Primary antibody incubation
was followed by the appropriate biotinylated antibody, ABC reagent
and NovaRed (Vector) mounted in Pertex (CellPath, Newtown, UK) or
streptavidin Cy3 secondary (Sigma-Aldrich, Poole, UK) mounted in
Mowiol containing DAPI (Sigma-Aldrich). Images were captured as
follows: bright field—Eclipse E600 microscope (Nikon, Kingston-
upon-Thames, UK) and spot camera (Image Solutions, Preston, UK);
picro Sirius red—plane polarized light microscope/camera (Leica,
Milton Keynes, UK); fluorescence—Leica MDLB/camera (Coolsnap,
Photometrics, Tucson, AZ). Image analysis was performed using
ImagePro Plus (Media Cybernetics, Rockville, MD) or Metamorph
software and Corel Paintshop Pro (Ottowa, Canada). Wound mea-
surements were made from hematoxylin and eosin-stained images.
Percentage re-epithelialization was quantified as follows: (distance
traveled by migrating epithelial tongue/total distance to travel)*100.
Wound width was quantified as the distance between normal dermal
architecture at the edge of each wound, and wound area was quan-
tified as the area of granulation tissue beneath the scab.
In vitro scratch wounding
The HaCaT human keratinocyte cell line was cultured at 37 C, 5%
CO2 in DMEM (Sigma-Aldrich) with 10% fetal bovine serum (Sigma-
Aldrich). Scratch wounds were generated in a confluent cell layer
using a 1-ml sterile pipette tip. mAbEDAR1 (10 mg, 50 mg) or
phosphate buffered saline was added, and 24 hours later cells
stained with crystal violet. Images were captured (Eclipse E600
microscope; Nikon) and cell migration quantified (ImagePro Plus;
Media Cybernetics). Cell migration was quantified as a percentage
increase in closure compared to scratches photographed at 0 hours,
and measurements were taken at 30 individual points across a single
scratch and averaged. Primary human keratinocytes were isolated
from adult female abdominal skin, cultured and scratched as
described earlier.
CL Garcin et al.
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Ex vivo methodology was as previously described (Stojandinovic
and Tomic-Canic, 2013) using tissue collected after ethical
approval was received. Briefly, adult female abdominal skin was
washed in sterile phosphate buffered saline (Sigma-Aldrich) and
excess fat removed. Each 8-mm-diameter biopsy-punched construct
was partial thickness wounded with a 3-mm punch. Constructs were
then cultured at the air-liquid interface in 1% antibiotic-antimycotic/
10% fetal bovine serum-supplemented DMEM (Sigma-Aldrich).
mAbEDAR1 or Aprily1 was applied directly to the central punch
wound. Biopsies were maintained at 37 C, 5% CO2 for 3 days, then
formalin fixed before tissue processing and sectioning as described
earlier.
Analysis of cell motility
Plate preparation. HaCaT cells at P41 were seeded into wells of
a 24-well plate at 1.5  104 cells per well. Just before imaging, cells
were treated with either mAbEdar1 or Aprily and imaged for 24
hours under wide-field live imaging microscope. Cell migration was
then analyzed as either track displacement (distance between start
point and endpoint) or track length (total distance traveled by the
cell) using a Wavelet plugin on Imaris (Egor Zindy, Zurich,
Switzerland).
Statistical analysis
Statistical differences were determined by the Student t test (SPSS).
P < 0.05 was considered significant.
Study approval
All animal work was approved by theUKHomeOffice (Project License
40/3202) following localethical approval.Humanskindonorsprovided
written consent before undergoing surgery, and tissue was handled
and stored in accordance with the Human Tissue Act (2004).
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